FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(037559301)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Rocuronium Bromide | 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Succinylcholine Chloride | 20 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 5 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ephedrine Sulfate | 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | "vasopressin, Unspecified" | 20 U/100 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .05 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .01 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .02 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate | .025 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Bupivacaine Hydrochloride | .002 mg/1 mL; 1.25 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Glycopyrrolate | .2 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Isoproterenol Hydrochloride | .004 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Labetalol Hydrochloride | 5 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Lidocaine Hydrochloride | 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Methadone Hydrochloride | 10 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Morphine Sulfate Anhydrous | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Morphine Sulfate Anhydrous | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Morphine Sulfate Anhydrous | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Morphine Sulfate Anhydrous | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Neostigmine Methylsulfate | 1 mg/1 mL | 2022-2 | source_no_ndc | 2026-11-10 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-781 | 70004-781-40 | Norepinephrine Bitartrate | .016 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-784 | 70004-784-40 | Norepinephrine Bitartrate | .032 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-771 | 70004-771-40 | Norepinephrine Bitartrate | .016 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-771 | 70004-771-44 | Norepinephrine Bitartrate | .016 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-785 | 70004-785-40 | Norepinephrine Bitartrate | .064 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-085 | 70004-085-44 | Oxytocin | 30 U | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-811 | 70004-811-12 | Phenylephrine Hydrochloride | .04 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-811 | 70004-811-40 | Phenylephrine Hydrochloride | .04 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-805 | 70004-805-40 | Phenylephrine Hydrochloride | .4 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-816 | 70004-816-12 | Phenylephrine Hydrochloride | .08 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-810 | 70004-810-11 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-810 | 70004-810-22 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-810 | 70004-810-12 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-808 | 70004-808-40 | Phenylephrine Hydrochloride | .08 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-825 | 70004-825-40 | Phenylephrine Hydrochloride | .16 mg/1 mL | 2022-2 | valid | 2026-11-10 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-806 | 70004-806-40 | Phenylephrine Hydrochloride | .2 mg/1 mL | 2022-2 | valid | 2026-11-10 |